Evonik is investing in a new GMP drug product manufacturing facility for lipid-based drug delivery in Vancouver, Canada. The facility will increase Evonik's development and manufacturing capacity, helping pharmaceutical and biotech customers bring lipid-based pharmaceutical products including vaccines, therapeutics, a…
BeOne Medicines, Ltd., a global oncology company, announced a $300 million expansion of its flagship clinical and commercial-stage manufacturing and research and development center at the Princeton West Innovation Campus in Hopewell, New Jersey, bringing total U.S. manufacturing investment to more than $1 billion. The…
Hovione, a globally-integrated specialist pharmaceutical CDMO, has completed expansion of the company’s tablet development and manufacturing center at its main global campus in Loures, Portugal adding 25 percent more commercial-scale batch tableting capacity for the integrated supply of oral solid dosage products. The…
Novotech, a leading global biotech CRO and full-service clinical research organization, has strengthened its established presence in Japan with the opening of a new office in Tokyo. The investment builds on Novotech’s existing operations and clinical trial activity in Japan and further enhances its ability to support …
Genentech, a member of the Roche Group announced plans to invest approximately $750 million in a new device fill-finish manufacturing facility at its 75-acre campus in Hillsboro, Oregon. The investment will bring new end-to-end device filling capabilities to the site and expand Genentech’s capacity to support its futu…
Intuitive, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery (RAS), announced that it has entered into a lease agreement with Penang Development Corporation (PDC) for its new manufacturing facility in Bandar Cassia Technology Park, Penang, Malaysia. The investment reflec…
Axtria Inc., a global leader in AI-first data analytics solutions for the life sciences industry, announced plans to expand its Forward Deployed Engineering (FDE) organization to 1,000 engineers by December 2026, creating the industry's largest pharma-specific AI engineering team. The expansion represents one of Axtri…
Bristol Myers Squibb (BMS) has announced the selection of Houston, Texas, as the site for a new, state-of-the-art multi-modal manufacturing campus, representing an approximately $2.3 billion investment designed to accelerate the delivery of next-generation medicines to patients. The campus, at Generation Park in Hous…
Cambrex, a leading global contract development and manufacturing organization (CDMO), announced the start of construction on a new research and development (R&D) facility at its Milan, Italy site. This $30 million investment will add advanced analytical development and process R&D capabilities, alongside upgra…
To meet growing customer demand globally, WuXi AppTec is increasing its capital expenditure at least 17% in 2026 to between RMB 6.5 billion and RMB 7.5 billion, as the company looks to add new drug substance and drug product manufacturing capacity over the next two years in Asia, Europe, and the United States. Among …
Page 4 of 61